Treatment Registry
TR-0751 ActiveRecorded September 2, 2026

Compounded semaglutide

Sold by Actin · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$169

Medication · 1-Month (Most Flexible)$169

Added from the figures recorded below.

Price

TermPer monthCharged today
1-Month (Most Flexible)

Most Flexible 1-Month $169

source

Per month$169Charged today$169
3-Month (Best Balance)

Best Balance 3-Month $143

source

Per month$143Charged today$143
6-Month (Best Savings)

Best Savings 6-Month $116

source

Per month$116Charged today$116
Visit Actin

We earn nothing from this link. Actin has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberAsynchronous review
Cancellation“YOU MAY CANCEL A SUBSCRIPTION AT ANY TIME THROUGH YOUR ACTIN HEALTH ACCOUNT OR BY CONTACTING ACTIN HEALTH, AND THE CANCELLATION WILL TAKE EFFECT THE DAY AFTER THE LAST DAY OF YOUR CURRENT SUBSCRIPTION PERIOD.”

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from actin.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Homepage badge literally reads 'No Membership Fees' and both product pages say 'Same price, forever' and 'No hidden fees or membership required' — the per-month figures already include the medication, this is not the membership trap. Per-month prices for the 3/6-month plans are the only figures printed; no separate upfront total was shown, so upfront was recorded equal to perMonth rather than computed. Device form (vial vs. pen) is never stated for either drug.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0751
Readings
1

Related records

What else Actin sells

All Actin programs and terms

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 298 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Actin compounded semaglutide (TR-0751). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0751

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.